Trump Floats Federal Approval for 'Natural 7-OH,' Pivoting From Administration's Scheduling Push

TL;DR

President Trump told reporters the administration is 'looking very seriously at natural 7-OH and getting that approved,' a statement that appears to contradict the FDA's July 2025 recommendation to classify the kratom compound as Schedule I. Separately, Idaho Falls is weighing a city-level kratom ban after six deaths in 18 months.

President Trump told reporters on Monday that his administration is "looking very seriously at natural 7-OH and getting that approved," a statement that appears to diverge sharply from his own FDA's recommendation last year to classify the kratom compound as a Schedule I controlled substance. The remark, reported by STAT News, came after a White House meeting on drug policy and immediately raised questions about what the president meant by "natural."

Trump's statement and the ambiguity at its center

7-hydroxymitragynine (7-OH) occurs naturally in kratom leaf at roughly two percent concentration. It also appears in concentrated extract products sold in gas stations and smoke shops at far higher levels, sometimes reaching 96 percent. The FDA's July 2025 scheduling recommendation, announced by Commissioner Marty Makary and HHS Secretary Robert Kennedy, targeted these concentrated products specifically.

Trump's use of the phrase "natural 7-OH" did not clarify which end of that spectrum he was referring to. Kratom Science reported that Makary's 2025 statements had implied natural leaf kratom would remain legal under the scheduling proposal, suggesting "natural 7-OH" could simply mean the trace compound as it exists in unprocessed leaf. But concentrated 7-OH vendors have also claimed the president's words as an endorsement of their products.

The statement does not change 7-OH's legal status. The FDA's scheduling recommendation remains with the DEA, which has not announced a timeline for proposed rulemaking. But the remark signals that the White House may be positioning itself between the FDA's enforcement posture and the kratom industry's resistance to broad scheduling.

Industry reaction was immediate and divided. The American Kratom Association, Consumer Choice Center, and manufacturers selling natural leaf products all claimed the statement supported their position, while concentrated 7-OH vendors read it as validation of their market. A fuller picture of the industry response is still developing.

Idaho Falls considers kratom ban after six deaths

In a separate development, the Idaho Falls City Council is considering a complete ban on kratom sales within city limits following six kratom-related death investigations in Bonneville County over the past 18 months. The victims ranged in age from 19 to 42.

Councilman Jim Freeman told LocalNews8 that constituent correspondence ran roughly two to one in favor of the ban, but noted that opponents are "well-funded and well-organized." The council tabled the vote to May 18 or June 1 to hear expert testimony.

The move follows a pattern documented across Washington State this month: when state legislatures fail to pass statewide frameworks, cities act on their own. Idaho, like Washington, has no state law regulating kratom, leaving the decision to individual municipalities.

Sources